Adèle R Weston, PhD

Adele-Weston145x145

Executive vice president and senior scientist, Health Economics and Outcomes, Asia Pacific

Dr Adèle Weston joined Optum through the acquisition of Sydney-based health economics consultancy HTanalysts where she was a founding director. Adèle has worked in health technology assessment and health economics consultancy for the past 14 years. During this time she has prepared several hundred PBAC and NICE reimbursement submissions as well as serving as a government HTA evaluator. Adèle has a particular interest in the integration of clinical and economic evidence in the evaluation of diagnostic, screening and targeted technologies. She is also active in the area of utility valuation and health care resource use quantification to demonstrate product value and defend price, with particular reference to the Asia Pacific region. Adèle has a PhD in physiology and has authored more than 25 peer-reviewed publications including The Lancet and NEJM. She has previously held academic appointments at the University of Natal Medical School and the University of Sydney. Adèle continues to serve on the Australian NHMRC panel of evidence-based health advice reviewers and provides methodological advice in the development of clinical practice guidelines to government and not-for-profit organisations.